Sysmex said blood-sample analyzers sold by Danaher’s Beckman Coulter unit infringe two patents for the technology.
- Sysmex is seeking cash compensation including lost profits and a reasonable royalty, and a court order blocking further unauthorized use of its inventions, according to complaint filed Sept. 3 in federal court in Wilmington, Delaware
- Targets include some of the UniCel DxH line of hematology analyzer systems, complaint says; systems include multiple detectors and also can analyze body fluids including cerebrospinal, thoracic, abdominal and others
- Patents were granted Sept. 3
CASE: Sysmex Corp. v. Beckman Coulter Inc., 19-cv-1642, U.S. District Court, District of ...